EPAM vs G
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
EPAM · EPAM Systems$159.31 ▼ 3.86%
G · Genpact$42.27 ▲ 2.85%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- EPAM -12.7%
- G -3.0%
Head to head
| Metric | EPAM | G |
|---|---|---|
| Price | $159.31 | $42.27 |
| Change today | ▼ 3.86% | ▲ 2.85% |
| Market cap | $8.13B | $7.07B |
| Return, 3 months | +63.6% | +24.5% |
| Return, year to date | -22.2% | -8.2% |
| Return, 1 year | -9.1% | -3.4% |
| P/E (TTM) | 20.0 | 12.3 |
| P/B | 2.3 | 2.6 |
| P/E percentile vs own 5y | 12th | 27th |
| Dividend yield | – | 1.73% |
| Revenue growth (YoY, latest qtr) | +4.5% | +7.1% |
| Net profit growth (YoY) | +17.0% | +9.8% |
| Gross margin | 29.4% | 36.5% |
| Operating margin | 10.0% | 15.0% |
| Net margin | 7.2% | 11.1% |
| Return on equity | 11.2% | 22.4% |
| Analyst target vs. price | -19.3% | -1.5% |
| Analyst buy share | 54% | 33% |
| RSI (14) | 71 | 71 |
| 30-day volatility | 69.4% | 39.9% |
| Max drawdown, 1 year | -65.7% | -42.7% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- EPAM is the largest of the group by market value.
- G has returned the most over the past year.
- G carries the lowest trailing P/E.
- G is growing revenue fastest.
- G keeps the most profit per dollar of sales.
- G has been the calmest stock over the last 30 days.